⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL394702 | 0.78 | — | — | |
| SCHEMBL7380936 | 0.71 | — | — | |
| SCHEMBL386020 | 0.67 | — | — | |
| SCHEMBL19348056 | 0.67 | — | — | |
| SCHEMBL6966072 | 0.67 | — | — | |
| Acetic Acid SCHEMBL23070489 | 0.67 | — | — | |
| SCHEMBL7923046 | 0.67 | — | — | |
| SCHEMBL14898055 | 0.67 | — | — | |
| SCHEMBL677890 | 0.67 | — | — | |
| SCHEMBL41116 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204407-B1 | PROCESS | GIVAUDAN SA (CH) | 2024-06-19 | — | — | EP | claimed |
| US-20230312506-A1 | PROCESS | GIVAUDAN SA (CH) | 2023-10-05 | — | — | US | claimed |
| EP-4204407-A1 | PROCESS | Givaudan SA (CH) | 2023-07-05 | — | — | EP | claimed |
| EP-2069291-B1 | HDAC INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2017-12-20 | — | — | EP | claimed |
| US-9725407-B2 | HDAC inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-08-08 | — | — | US | claimed |
| US-20160137594-A1 | HDAC INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2016-05-19 | — | — | US | claimed |
| US-9133104-B2 | Enzyme inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2015-09-15 | — | — | US | claimed |
| US-20150126534-A1 | ENZYME AND RECEPTOR MODULATION | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-05-07 | — | — | US | claimed |
| US-8962825-B2 | Hydroxamates as inhibitors of histone deacetylase | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-02-24 | — | — | US | claimed |
| US-20140163042-A1 | ENZYME INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2014-06-12 | — | — | US | claimed |
| EP-0409413-A2 | Diaryl ether heterocycles | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-01-23 | — | — | EP | claimed |
| US-4970224-A | INSECTICIDES | ROHM AND HAAS COMPANY (US) | 1990-11-13 | — | — | US | claimed |
| EP-0338685-A1 | 1-Dimethylcarbamoyl-3-substituted-5-substituted-1H-1,2,4-triazoles | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-10-25 | — | — | EP | claimed |
| EP-0337815-A1 | 1-dimethylcarbamoyl-3-substituted-5-substituted-1H-1,2,4-triazoles | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-10-18 | — | — | EP | claimed |
| EP-0213718-A2 | 1-Dimethylcarbamoyl-3-substituted-5-substituted-1H-1,2,4-triazoles | ROHM AND HAAS COMPANY (US) | 1987-03-11 | — | — | EP | claimed |
| EP-0024257-B1 | N-(2-ISOBUTYRONITRILE SULFENYL)-N-METHYL-OXIME CARBAMATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES | CIBA-GEIGY AG (CH) | 1983-12-14 | — | — | EP | claimed |
| EP-0079467-A1 | N-substituted O-pyrazol-4-yl-carbamic-acid esters, process for their preparation and their use as biocides | BAYER AG (DE) | 1983-05-25 | — | — | EP | claimed |
| US-4249937-A | 2-(1-ALKYLOXYAMINO-ALKYLIDENE)-5-(ALKYL OR ARYL-SULFENYL, SULFINYL-ALKYL)-1,3-CYCLOHEXADIONE HERBICIDES | NIPPON SODA COMPANY, LTD. (JP) | 1981-02-10 | — | — | US | claimed |
| US-4059699-A | O,O-diethyl-O-carboxamidophosphate esters and use to combat insects and mites | GULF OIL CORPORATION (US) | 1977-11-22 | — | — | US | claimed |
| US-3994997-A | MITICIDES, INSECTICIDES | GULF OIL CORPORATION (US) | 1976-11-30 | — | — | US | claimed |